Getinge (OTCMKTS:GNGBY) Sets New 52-Week High – Here’s Why

Shares of Getinge (OTCMKTS:GNGBY) hit a new 52-week high during trading on Thursday . The stock traded as high as $24.67 and last traded at $24.67, with a volume of 167 shares changing hands. The stock had previously closed at $24.25.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Getinge from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Strong Buy”.

Getinge Stock Performance

The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 1.31. The stock has a market cap of $6.72 billion, a PE ratio of 23.50 and a beta of 0.96. The company’s 50 day simple moving average is $21.21 and its 200 day simple moving average is $21.33.

Getinge (OTCMKTS:GNGBY) last announced its earnings results on Friday, July 17th. The company reported $0.38 earnings per share for the quarter. The firm had revenue of $894.87 million for the quarter. Getinge had a return on equity of 11.12% and a net margin of 7.81%. Analysts expect that Getinge will post 1.38 earnings per share for the current year.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.